Call or text us!
MEET OUR DOCTORS
DR. MICHAEL SEDRAK
DR. PAUL BRESSMAN
Dr. Paul Bressman M.D. is a Diplomate of the American Board of Surgery, a Fellow of the American College of Surgery (FACS) and a Registered Vascular Technician (RVT) and completed an additional clinical fellowship in peripheral vascular surgery at Cedars Sinai Medical Center in Los Angeles, California.
Dr. Bressman is a Diplomate of the American Board of Phlebology and has dedicated his practice to taking care of patients with the full spectrum of venous disorders. Your treatment will be based upon a complete consultation, a full venous duplex ultrasound examination, and tailored to meet your unique needs. We employ both Laser and Vnus Coviden Radiofrequency endovenous ablation therapy, ultrasound guided foam sclerotherapy and Microphlebectomy and will utilize your PPO or Medicare Insurance benefits whenever possible. Most importantly you are placing your problems in hands of a master surgeon with lifetime of experience and a dedication to the art and science of your problem.
In his spare time Dr. Bressman likes being active and loves biking with his family,
The AHA (American Heart Association) recently estimated that the annual rate of new heart attacks inUnited States is 785,000, another 470,000 will have a recurrent heart attack and another 195,000 will have a silent heart attack. The figures for stroke (cerebrovascular accident, CVA) are not much better: 610,000 new strokes a year and 185,000 recurrent strokes each year.
Fortunately today with the rapid advances in non invasive DNA based technology we are able to take a more proactive and scientific approach to optimize our own unique metabolism inorder to improve our healthcare. The recent improvements in non invasive laboratory testing have enabled us to start identifying the subclinical root causes responsible for our illnesses. Maladaption to our life stressors can lead to insulin resistance and alteration in our Pituitary Adrenal Thyroid Axis response systems. By identifying these alterations as early as possible we can not only prevent the progression of these problemwe can actually begin reverse this disease process.
There is no short answer and every intervention is based on modulating our lifestyle (diet, exercise and sleep) and adding proven effective supplements or medications to increase our concentration of the beneficial fraction of our High Density Lipids ( HDL 2b %) and decrease the inflammatory risk factors (hsCRP, Lp(a), LP-PLA2, MPO, ApoE, LDL IIIa+b, Fibrinogen, oxidized fatty acids) that precipitate intimal failure and plaque rupture.
The Metabolic Code and Bale Doneen Method are prime example of this. Plaque formation is not a normal sign of aging and can be reversed. Carotid intima media testing (CIMT) is the most sensitive, least invasive and least costly method of physically determining subclinical atherosclerosis. Advanced lipid profiles and genetic testing as employed by Berkeley Heart Lab, Spectracell Laboratories, and Genova Diagnostics Laboratory are some of the modern tools that now give us the ability to objectively identify risk factors before diseases are established. These new technologies allow us to scientifically create a treatment plan to optimize your health, measure your treatment response, and guide your therapy to meet the changes in our lives.
Dr.Zuberi M.D. is a board certified, minimally invasive specialist.
He has special interests in surgical and endoscopic management for GERD, bariatric surgery and weight loss management,
robotic surgery, advanced endoscopy and general surgery.
Dr.Zuberi clinical experience includes Sanford Bemidji Main Clinic, CHI Lakewood Health Center and Beaumont Hospital.
EDUCATION AND CERTIFICATIONS
Dr.Zuberi graduated from and served his residency at the Royal College of Surgeons in Dublin, Ireland. (RCSI).
He went on to also serve his residency at Johns Hopkins School of Medicine and Medical Institutions in Baltimore, MD, and the Marshfield Clinic and St.Joseph's Hospital in Marshfield, WI,
Dr.Zuberi completed his internships at Beaumont Hospital and The Royal Colleg